Fig. 4.

Clinical feature correlation and survival analysis of potential HNSCC-associated lncRNAs

(a) Correlation of CYTOR expression with lymph node metastasis in HNSCC patients. (b) Correlation of HCG22 expression with gender, age, and tumor size in HNSCC patients. (c, d) Kaplan-Meier analysis of overall survival in HNSCC patients with CYTOR (c) and HCG22 (d) expression. HNSCC patients with higher HCG22 and lower CYTOR expression have a better overall survival. P-values were calculated by log-rank test